We are live on ! Find out more
HALO icon

Halozyme

224 hedge funds and large institutions have $2.27B invested in Halozyme in 2019 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 76 increasing their positions, 64 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more call options, than puts

Call options by funds: $22.3M | Put options by funds: $7.15M

63% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 32

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

19% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 64

16% more capital invested

Capital invested by funds: $1.96B → $2.27B (+$305M)

7% more funds holding

Funds holding: 210224 (+14)

0.78% more ownership

Funds ownership: 86.45%87.23% (+0.78%)

Holders
224
Holders Change
+14
Holders Change %
+6.67%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
52
Increased
76
Reduced
64
Closed
32
Calls
$22.3M
Puts
$7.15M
Net Calls
+$15.2M
Net Calls Change
+$6.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Fisher Asset Management
26
Fisher Asset Management
Washington
$21M +$221K +12,747 +1%
Thrivent Financial for Lutherans
27
Thrivent Financial for Lutherans
Minnesota
$20.9M -$46.6M -2,688,279 -70%
Adage Capital Partners
28
Adage Capital Partners
Massachusetts
$19.9M +$6.49M +375,000 +50%
UBS AM
29
UBS AM
Illinois
$18.8M +$2.93M +169,391 +19%
Millennium Management
30
Millennium Management
New York
$18.7M +$12.8M +739,802 +235%
CTA
31
Carillon Tower Advisers
Florida
$18.7M
Wells Fargo
32
Wells Fargo
California
$17.6M +$334K +19,272 +2%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$17.5M +$11M +636,500 +182%
Goldman Sachs
34
Goldman Sachs
New York
$16M -$12.1M -699,487 -44%
LOAMS
35
Lombard Odier Asset Management (Switzerland)
Switzerland
$16M +$10.4M +600,000 +200%
Charles Schwab
36
Charles Schwab
California
$15.7M -$322K -18,584 -2%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$15.6M -$2.62M -151,424 -15%
CS
38
Candriam SCA
Luxembourg
$14.5M +$2.91M +168,193 +26%
SCM
39
Scopia Capital Management
New York
$13.1M +$12.8M +739,479 New
Deutsche Bank
40
Deutsche Bank
Germany
$12.9M +$6.11M +352,685 +95%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$11.4M +$21.4K +1,234 +0.2%
ECP
42
Elk Creek Partners
Colorado
$11.3M -$2.07M -119,683 -16%
PHS
43
PFM Health Sciences
California
$10.5M +$10.3M +593,480 New
Morgan Stanley
44
Morgan Stanley
New York
$10.4M +$1.02M +58,984 +11%
American Century Companies
45
American Century Companies
Missouri
$9.62M -$276K -15,928 -3%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$9.56M +$4.2M +242,426 +82%
Man Group
47
Man Group
United Kingdom
$8.25M -$4.55M -262,679 -36%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$8.1M +$7.46M +430,815 +1,662%
Ameriprise
49
Ameriprise
Minnesota
$6.99M -$205K -11,823 -3%
Arrowstreet Capital
50
Arrowstreet Capital
Massachusetts
$6.85M +$4.8M +277,395 +255%

HALO Hedge Fund Activity: Q4 2019 in Review

224 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2019, worth a combined $2.27B — up 16% from $1.96B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new HALO positions and 32 closed out — a net gain of 20 holders — while 76 added to existing stakes and 64 trimmed.

The largest buyer was Artisan Partners, adding an estimated $36.4M. The largest seller was Iridian Asset Management, cutting an estimated $75.4M.

  • 224 institutional investors held Halozyme (HALO) as of Q4 2019, up from 210 in Q3 2019.
  • Funds reported $2.27B of Halozyme stock for Q4 2019, up 16% quarter-over-quarter.
  • 52 funds opened new Halozyme positions in Q4 2019 and 32 closed out, a net change of +20 holders.
  • The largest Halozyme buyer in Q4 2019 was Artisan Partners, an estimated $36.4M added.
  • The largest Halozyme seller in Q4 2019 was Iridian Asset Management, an estimated $75.4M sold.

Based on aggregated 13F filings for Q4 2019.